DK0828494T3 - Fremgangsmåde til behandling af kognitiv dysfunktion - Google Patents
Fremgangsmåde til behandling af kognitiv dysfunktionInfo
- Publication number
- DK0828494T3 DK0828494T3 DK95922148T DK95922148T DK0828494T3 DK 0828494 T3 DK0828494 T3 DK 0828494T3 DK 95922148 T DK95922148 T DK 95922148T DK 95922148 T DK95922148 T DK 95922148T DK 0828494 T3 DK0828494 T3 DK 0828494T3
- Authority
- DK
- Denmark
- Prior art keywords
- cognitive dysfunction
- treatment
- methyl
- benzodiazepine
- thieno
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Percussion Or Vibration Massage (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Radiation-Therapy Devices (AREA)
- Pretreatment Of Seeds And Plants (AREA)
- Light Receiving Elements (AREA)
- Processing Of Meat And Fish (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US1995/006859 WO1996038151A1 (en) | 1995-05-30 | 1995-05-30 | Method for treating cognitive dysfunction |
| CA002219902A CA2219902A1 (en) | 1995-05-30 | 1995-05-30 | Use of 2-methyl-4-(4-methyl-1-piperazinyl)-10h-thieno¬2,3b|¬1,5|benzodiazepine for treating cognitive dysfunction |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0828494T3 true DK0828494T3 (da) | 2002-09-02 |
Family
ID=25679786
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK95922148T DK0828494T3 (da) | 1995-05-30 | 1995-05-30 | Fremgangsmåde til behandling af kognitiv dysfunktion |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0828494B1 (cs) |
| JP (1) | JPH11506096A (cs) |
| AT (1) | ATE220550T1 (cs) |
| AU (1) | AU707858B2 (cs) |
| CZ (1) | CZ292565B6 (cs) |
| DE (1) | DE69527442T2 (cs) |
| DK (1) | DK0828494T3 (cs) |
| ES (1) | ES2180643T3 (cs) |
| FI (1) | FI973987A0 (cs) |
| HU (1) | HUT77907A (cs) |
| MX (1) | MX9707936A (cs) |
| NO (1) | NO318553B1 (cs) |
| NZ (1) | NZ288037A (cs) |
| PL (1) | PL189714B1 (cs) |
| PT (1) | PT828494E (cs) |
| WO (1) | WO1996038151A1 (cs) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3274579B2 (ja) * | 1995-01-12 | 2002-04-15 | 住友製薬株式会社 | 脳血管障害に伴う精神症候治療剤 |
| UA57727C2 (uk) * | 1996-03-11 | 2003-07-15 | Елі Ліллі Енд Компані | Спосіб лікування надмірної агресивності |
| PL196814B1 (pl) | 2002-05-17 | 2008-02-29 | Inst Farmaceutyczny | Sposób wytwarzania odmiany polimorficznej I olanzapiny i jej solwaty |
| WO2005070938A1 (en) | 2004-01-27 | 2005-08-04 | Synthon B.V. | Stable salts of olanzapine |
| PT1838716E (pt) | 2005-01-05 | 2011-07-15 | Lilly Co Eli | Di-hidrato de pamoato de olanzapina |
| PL381564A1 (pl) | 2007-01-22 | 2008-08-04 | Koźluk Tomasz Nobilus Ent | Sposób wytwarzania zasadniczo czystej odmiany polimorficznej I olanzapiny |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5270464A (en) * | 1989-03-14 | 1993-12-14 | Janssen Pharmaceutica N.V. | Anti-HIV-1 tetrahydroimidazo[1,4]benzodiazepin-2-(thi) ones |
| GB9009229D0 (en) * | 1990-04-25 | 1990-06-20 | Lilly Industries Ltd | Pharmaceutical compounds |
-
1995
- 1995-05-30 DK DK95922148T patent/DK0828494T3/da active
- 1995-05-30 AU AU26936/95A patent/AU707858B2/en not_active Ceased
- 1995-05-30 PL PL95323785A patent/PL189714B1/pl not_active IP Right Cessation
- 1995-05-30 EP EP95922148A patent/EP0828494B1/en not_active Expired - Lifetime
- 1995-05-30 ES ES95922148T patent/ES2180643T3/es not_active Expired - Lifetime
- 1995-05-30 HU HU9801173A patent/HUT77907A/hu not_active Application Discontinuation
- 1995-05-30 DE DE69527442T patent/DE69527442T2/de not_active Expired - Fee Related
- 1995-05-30 PT PT95922148T patent/PT828494E/pt unknown
- 1995-05-30 AT AT95922148T patent/ATE220550T1/de not_active IP Right Cessation
- 1995-05-30 FI FI973987A patent/FI973987A0/fi not_active IP Right Cessation
- 1995-05-30 NZ NZ288037A patent/NZ288037A/en unknown
- 1995-05-30 JP JP8536420A patent/JPH11506096A/ja active Pending
- 1995-05-30 CZ CZ19973243A patent/CZ292565B6/cs not_active IP Right Cessation
- 1995-05-30 WO PCT/US1995/006859 patent/WO1996038151A1/en active IP Right Grant
- 1995-05-30 MX MX9707936A patent/MX9707936A/es not_active IP Right Cessation
-
1997
- 1997-10-15 NO NO19974766A patent/NO318553B1/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2180643T3 (es) | 2003-02-16 |
| NO974766D0 (no) | 1997-10-15 |
| PL189714B1 (pl) | 2005-09-30 |
| WO1996038151A1 (en) | 1996-12-05 |
| MX9707936A (es) | 1997-12-31 |
| DE69527442D1 (de) | 2002-08-22 |
| CZ292565B6 (cs) | 2003-10-15 |
| PT828494E (pt) | 2002-10-31 |
| EP0828494A1 (en) | 1998-03-18 |
| PL323785A1 (en) | 1998-04-27 |
| NO974766L (no) | 1997-12-09 |
| DE69527442T2 (de) | 2003-02-20 |
| HUT77907A (hu) | 1998-10-28 |
| EP0828494B1 (en) | 2002-07-17 |
| CZ324397A3 (cs) | 1998-08-12 |
| EP0828494A4 (en) | 1999-11-24 |
| AU2693695A (en) | 1996-12-18 |
| ATE220550T1 (de) | 2002-08-15 |
| AU707858B2 (en) | 1999-07-22 |
| FI973987L (fi) | 1997-10-17 |
| NO318553B1 (no) | 2005-04-11 |
| NZ288037A (en) | 1999-09-29 |
| JPH11506096A (ja) | 1999-06-02 |
| FI973987A7 (fi) | 1997-10-17 |
| FI973987A0 (fi) | 1997-10-17 |
| HK1009393A1 (en) | 1999-06-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY114701A (en) | Process and crystal forms of 2-methyl-thieno- benzodiazepine | |
| IL117971A0 (en) | Method for treating dyskinesias | |
| DE60336226D1 (de) | Verfahren zur herstellung von olanzapin form i | |
| NZ510208A (en) | Olanzapine (2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine) pamoate salt | |
| EP1181935A3 (en) | Agent for treating mental disorders associated with cerebrovascular disorders | |
| ZA971566B (en) | Method of treating leather with pmphoteric polymers. | |
| DK0828494T3 (da) | Fremgangsmåde til behandling af kognitiv dysfunktion | |
| NZ332037A (en) | Olanzapine for treating migraine pain | |
| DK0733634T3 (da) | Fremgangsmåde til fremstilling af et thieno(2,3-b) (1,5)benzodiazepinderivat | |
| PL325201A1 (en) | Sewage treating process | |
| TW429149B (en) | Pharmaceutical composition for treating conditions resulting from the cessation and withdrawal from the use of nicotine | |
| FI980091A0 (fi) | Menetelmä ylijäämäaktiivilietteen käsittelemiseksi | |
| ZA976854B (en) | Treatment of psychotic disorders. | |
| DK0773192T3 (da) | Fremgangsmåde til behandling af selenholdigt spildevand | |
| ES2185777T3 (es) | Tratamiento de la anorexia. | |
| HUP9902882A2 (hu) | Olanzapin alkalmazása álmatlanság kezelésére szolgáló gyógyszerkészítmények előállítására | |
| ZA966936B (en) | Process for the treatment of water. | |
| ES1033530Y (es) | Aparato para depurar aguas residuales. | |
| ZA966815B (en) | Method of treating water. | |
| ZA963472B (en) | Method of treatment. | |
| ZA991836B (en) | Method of treating sewage. |